# NetTargets

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nettargets

- Industry: Biotechnology
- Headquarters: Daejeon, South Korea
- Website: www.net-targets.com
- Total disclosed funding: $5.3M
- Latest round: Series A (Jul 2, 2021)
- Investors on record: 9

## About

Based in Daejeon, South Korea, and founded in 2019 by Je-Hoon Song, and Jongho Baek (CEO), NetTargets Inc. operates as a biotechnology company that utilizes artificial intelligence to discover new drug candidates. In July 2021, NetTargets Inc. raised KRW 6 billion in series A funding from Winvest Venture Capital and Friend Investment Partners, with participation from BS Investment Partners, CKD Venture Capital, etc. 

NetTargets Inc. is a developer of a drug development technology system based on systems biology research that is intended to provide an efficient method of drug discovery. The company's system aids in drug discovery by providing interpretable predictions, allowing clinicians to make the best decisions for successful drug development. The company's software consists of a drug database and a mechanism analysis platform that reduce the cost and time of drug development.

The company plans to use the July 2021 funding to make improvements to its drug target discovery technology and invest in research and development of new drug candidates.

## Funding rounds

- Series A, Jul 2, 2021, $5.3M — CKD Venture Capital, Friend Investment Partners, DA Value Investment, Square Ventures, Winvest Venture Capital, GU Equity Partners, We Ventures, BS Investment Partners
- Seed, Oct 25, 2019 — Bluepoint Partners

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- CKD Venture Capital (https://capitalatlas.ai/funds/ckd-venture-capital) — Series A
- Friend Investment Partners (https://capitalatlas.ai/funds/friend-investment-partners) — Series A
- DA Value Investment (https://capitalatlas.ai/funds/da-value-investment) — Series A
- Square Ventures (https://capitalatlas.ai/funds/square-ventures) — Series A
- Winvest Venture Capital (https://capitalatlas.ai/funds/winvest-venture-capital) — Series A
- GU Equity Partners (https://capitalatlas.ai/funds/gu-equity-partners) — Series A
- We Ventures — Series A
- BS Investment Partners (https://capitalatlas.ai/funds/bs-investment-partners) — Series A